Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 164.80
Bid: 163.60
Ask: 167.00
Change: 0.00 (0.00%)
Spread: 3.40 (2.078%)
Open: 164.80
High: 164.80
Low: 164.80
Prev. Close: 164.80
CCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Change in C&C’s Listing Arrangements and Notice of Half Year Results

10 Sep 2019 07:00

 

C&C Group plc

(‘C&C’ or the ‘Group’)

Change in C&C’s Listing Arrangements

and

Notice of Half Year Results

Change in Listing Arrangements

Following the AGM Statement released by the Group on 4 July 2019, the Board has been reviewing and seeking the views of a wide range of shareholders on the listing arrangements for C&C’s shares.

In determining the most appropriate arrangements for the listing of C&C’s shares, the Board has had regard to:

Following the acquisition of Matthew Clark and Bibendum in 2018, a majority of the Group’s revenues, earnings and activities are now derived in and from the United Kingdom and there has been a consequent reduction in the proportion of C&C’s revenue and profit earned in Ireland;The continued evolution of C&C’s shareholder base, with a majority of the Group’s shares now held by shareholders based in the UK and North America; andThe potential benefits of C&C being included in the FTSE UK Index Series which the Board believes is likely over time to increase awareness of C&C among the investor community.

Following the completion of its review, the Board has determined that it is appropriate for C&C to seek admission to the FTSE UK Index Series. This will entail cancelling the listing of the Group’s shares on Euronext Dublin while maintaining the Premium Listing of C&C’s shares on the Official List of the UK Financial Conduct Authority (“FCA Official List”). The currency in which C&C’s shares are traded on the London Stock Exchange will change from Euro to Sterling with effect from 7 October 2019.

Therefore, with effect from the close of business on 7 October 2019, C&C’s listing on the Official List of Euronext Dublin will be cancelled pursuant to Euronext Dublin Listing Rule 5.3 (“the Cancellation”). The Cancellation is not subject to the approval of shareholders. Up until close of business on 7 October 2019, C&C’s shares will continue to trade on Euronext Dublin in Euro. After this date, C&C’s shares will be traded solely on the London Stock Exchange in Sterling.

The FTSE Nationality Committee, which determines eligibility for the FTSE UK Index Series, is scheduled to meet on 6 November 2019 in advance of the FTSE quarterly review on 4 December 2019. It is anticipated that, subject inter alia to the proposed changes to C&C’s listing arrangements set out above having taken place and the independent deliberations of the FTSE committees including amongst other conditions, C&C passing certain liquidity and size thresholds on the London Stock Exchange, C&C would be included in the FTSE All-Share Index and the FTSE 250 from 23 December 2019.

C&C will continue to adhere to the principles of the UK Corporate Governance Code, pre-emption rights and will remain subject to all of the super-equivalent regulatory obligations consequent to its continued Premium Listing on the FCA Official List. C&C will, following cancellation of the listing on Euronext Dublin, become subject to the shared jurisdiction of the UK Panel on Takeovers and Mergers and the Irish Takeover Panel and accordingly will continue to adhere to the principles of the UK City Code on Takeovers and Mergers. Accordingly, there will be no material effect on the shareholder rights and investor protections currently applicable to an investment in C&C.

Likewise, these changes will not have any impact on the domicile or operations of C&C.

Notice of Half Year Results

C&C announces that financial results for the half year ended 31 August 2019, will be issued on Thursday, 24 October 2019 at 07:00 BST (02:00 ET).

ENDS

Contacts

C&C Group plcStephen Glancey | Group Chief ExecutiveJonathan Solesbury | Group Chief Financial OfficerPatrick McMahon | Group Strategy DirectorTel: +353 86 389 0007Email:patrick.mcmahon@candcgroup.ie

FTI ConsultingJonathan Neilan/Paddy BerkeryTel: +353 1 765 0886Email:CandCGroup@fticonsulting.com

Novella CommunicationsTim RobertsonTel: +44 203 151 7008Email:TimR@novella-comms.com

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

C&C Group’s portfolio of owned/exclusive brands include: Bulmers, the leading Irish cider brand; Tennent’s, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of fast-growing, super-premium and craft ciders and beers, such as Heverlee, Menabrea and Orchard Pig. C&C exports its Magners and Tennent’s brands to over 60 countries worldwide.C&C Group has owned brand and contract manufacturing/packing operations in Co. Tipperary, Ireland; Glasgow, Scotland; and Vermont, US, where it manufactures Woodchuck, a leading craft cider brand in the United States.C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating under the Matthew Clark, Bibendum, Tennent's and C&C Gleeson brands, the Group supplies over 35,000 pubs, bars, restaurants and hotels, and is a key route-to-market for major international beverage companies.C&C Group also has an investment in the Admiral Taverns tenanted pub group, which owns over 800 pubs across England & Wales.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20190909005813/en/

Copyright Business Wire 2019

Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20244:30 pmRNSDirector/PDMR Shareholding
16th Apr 202410:30 amRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20245:15 pmRNSTotal Voting Rights and Capital
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20243:25 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20242:55 pmRNSTotal Voting Rights and Capital
22nd Feb 20245:31 pmRNSHolding(s) in Company
21st Feb 20247:00 amRNSLaunch of EUR 15 Million Share Buyback Programme
15th Feb 20246:00 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSDirectorate Changes
2nd Feb 202410:00 amRNSTotal Voting Rights and Capital
15th Jan 20242:20 pmRNSDirector/PDMR Shareholding
4th Jan 202412:45 pmRNSTotal Voting Rights
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
12th Dec 20231:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.